SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950123-10-034725
Filing Date
2010-04-14
Accepted
2010-04-14 13:59:56
Documents
5
Period of Report
2010-05-20
Effectiveness Date
2010-04-14

Document Format Files

Seq Description Document Type Size
1 DEF 14A w78089def14a.htm DEF 14A 462297
2 GRAPHIC w78089w7808900.gif GRAPHIC 1282
3 GRAPHIC w78089w7808901.gif GRAPHIC 1134
4 GRAPHIC w78089w7808902.gif GRAPHIC 2126
5 GRAPHIC w78089w7808903.gif GRAPHIC 2706
  Complete submission text file 0000950123-10-034725.txt   474310
Mailing Address 4520 EAST-WEST HIGHWAY, SUITE 300 BETHESDA MD 20814
Business Address 4520 EAST-WEST HIGHWAY, SUITE 300 BETHESDA MD 20814 3019613400
Sucampo Pharmaceuticals, Inc. (Filer) CIK: 0001365216 (see all company filings)

IRS No.: 133929237 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-33609 | Film No.: 10749046
SIC: 2834 Pharmaceutical Preparations